Unknown

Dataset Information

0

Seroprevalence of COVID-19 in Riyadh city during the early increase of COVID-19 infections in Saudi Arabia, June 2020.


ABSTRACT: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) emerged in December 2019 and caused a global pandemic of the Coronavirus Disease 2019 (COVID-19). More than 170 million cases have been reported worldwide with mortality rate of 1-3%. The detection of SARS-CoV-2 by molecular testing is limited to acute infections, therefore serological studies provide a better estimation of the virus spread in a population. This study aims to evaluate the seroprevalence of SARS-CoV-2 in the major city of Riyadh, Saudi Arabia during the sharp increase of the pandemic, in June 2020. Serum samples from non-COVID patients (n = 432), patients visiting hospitals for other complications and confirmed negative for COVID-19, and healthy blood donors (n = 350) were collected and evaluated using an in-house enzyme-linked immunosorbent assay (ELISA). The overall percentage of positive samples was 7.80% in the combined two populations (n = 782). The seroprevalence was lower in the blood donors (6%) than non-COVID-19 patients (9.25%), p = 0.0004. This seroprevalence rate is higher than the documented cases, indicating asymptomatic or mild unreported COVID-19 infections in these two populations. This warrants further national sero-surveys and highlights the importance of real-time serological surveillance during pandemics.

SUBMITTER: Alenazi MW 

PROVIDER: S-EPMC9027288 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Seroprevalence of COVID-19 in Riyadh city during the early increase of COVID-19 infections in Saudi Arabia, June 2020.

Alenazi Mohammed W MW   Algaisi Abdullah A   Zowawi Hosam M HM   Aldibasi Omar O   Hashem Anwar M AM   Alharbi Naif Khalaf NK  

Saudi journal of biological sciences 20220422 6


Severe acute respiratory syndrome coronavirus (SARS-CoV-2) emerged in December 2019 and caused a global pandemic of the Coronavirus Disease 2019 (COVID-19). More than 170 million cases have been reported worldwide with mortality rate of 1-3%. The detection of SARS-CoV-2 by molecular testing is limited to acute infections, therefore serological studies provide a better estimation of the virus spread in a population. This study aims to evaluate the seroprevalence of SARS-CoV-2 in the major city of  ...[more]

Similar Datasets

| S-EPMC8867694 | biostudies-literature
| S-EPMC6454662 | biostudies-literature
| S-EPMC9278404 | biostudies-literature
| S-EPMC7998056 | biostudies-literature
| S-EPMC7832465 | biostudies-literature
| S-EPMC8384767 | biostudies-literature
| S-EPMC10530388 | biostudies-literature
| S-EPMC8590599 | biostudies-literature
| S-EPMC8084513 | biostudies-literature
| S-EPMC9367174 | biostudies-literature